Skip to main content
Top
Published in: BMC Neurology 1/2010

Open Access 01-12-2010 | Research article

Validation, reproducibility and safety of trans dermal electrical stimulation in chronic pain patients and healthy volunteers

Authors: Remigiusz Lecybyl, Juan Acosta, Joydeep Ghoshdastidar, Kinga Stringfellow, Magdi Hanna

Published in: BMC Neurology | Issue 1/2010

Login to get access

Abstract

Background

Surrogate pain models have been extensively tested in Normal Human Volunteers (NHV). There are few studies that examined pain models in chronic pain patients. Patients are likely to have altered pain mechanisms. It is of interest to test patient pain responses to selective pain stimuli under controlled laboratory conditions.

Methods

The Institutional Ethic Committee approved the study. 16 patients with chronic neuropathic radiculopathy and 16 healthy volunteers were enrolled to the study after obtaining informed consent. During electrical stimulation (150 minutes for volunteers and 75 minutes for patients) the following parameters were measured every 10 minutes:
Ongoing pain: Visual Analogue Scale (VAS) and Numeric Rate Scale (NRS)
Allodynia (soft foam brush)
Hyperalgesia (von Frey monofilament 20 g)
Flare
For each endpoint, the area under the curve (AUC) was estimated from the start of stimulation to the end of stimulation by the trapezoidal rule. The individual AUC values for both periods were plotted to show the inter- and intra-subject variability. For each endpoint a mixed effect model was fitted with random effect subject and fixed effect visit. The estimate of intra-subject variance and the mean value were then used to estimate the sample size of a crossover study required to have a probability of 0.80 to detect a 25% change in the mean value. Analysis was done using GenStat 8th edition.

Results

Each endpoint achieved very good reproducibility for patients and NHV. Comparison between groups revealed trends towards:
Faster habituation to painful stimuli in patients
Bigger areas of hyperalgesia in patients
Similar area of allodynia and flare (no statistical significance)

Conclusion

The differences demonstrated between patients and NHVs suggest that the electrical stimulation device used here may stimulate pathways that are affected in the pathological state.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vierck CJ, Hansson PT, Yezierski RP: Clinical and pre-clinical pain assessment: are we measuring the same thing?. Pain. 2008, 135 (1-2): 7-10. 10.1016/j.pain.2007.12.008.CrossRefPubMed Vierck CJ, Hansson PT, Yezierski RP: Clinical and pre-clinical pain assessment: are we measuring the same thing?. Pain. 2008, 135 (1-2): 7-10. 10.1016/j.pain.2007.12.008.CrossRefPubMed
2.
go back to reference Goldstein DJ, Wang O, Todd LE, Gitter BD, DeBrota DJ, Iyengar S: Study of the analgesic effect of lanepitant in patients with osteoarthritis pain. Clinical pharmacology and therapeutics. 2000, 67 (4): 419-426. 10.1067/mcp.2000.105243.CrossRefPubMed Goldstein DJ, Wang O, Todd LE, Gitter BD, DeBrota DJ, Iyengar S: Study of the analgesic effect of lanepitant in patients with osteoarthritis pain. Clinical pharmacology and therapeutics. 2000, 67 (4): 419-426. 10.1067/mcp.2000.105243.CrossRefPubMed
3.
go back to reference Hill R: NK1 (substance P) receptor antagonists--why are they not analgesic in humans?. Trends in pharmacological sciences. 2000, 21 (7): 244-246. 10.1016/S0165-6147(00)01502-9.CrossRefPubMed Hill R: NK1 (substance P) receptor antagonists--why are they not analgesic in humans?. Trends in pharmacological sciences. 2000, 21 (7): 244-246. 10.1016/S0165-6147(00)01502-9.CrossRefPubMed
4.
go back to reference Arendt-Nielsen L, Curatolo M, Drewes A: Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs. 2007, 8 (1): 41-53.PubMed Arendt-Nielsen L, Curatolo M, Drewes A: Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs. 2007, 8 (1): 41-53.PubMed
5.
go back to reference Bromm B, Meier W, Scharein E: Imipramine reduces experimental pain. Pain. 1986, 25: 245-57. 10.1016/0304-3959(86)90100-4.CrossRefPubMed Bromm B, Meier W, Scharein E: Imipramine reduces experimental pain. Pain. 1986, 25: 245-57. 10.1016/0304-3959(86)90100-4.CrossRefPubMed
6.
7.
go back to reference Inui K, Tran TD, Hoshiyama M, Kakigi R: Preferential stimulation of Adelta fibers by intra-epidermal needle electrode in humans. Pain. 2002, 96: 247-52. 10.1016/S0304-3959(01)00453-5.CrossRefPubMed Inui K, Tran TD, Hoshiyama M, Kakigi R: Preferential stimulation of Adelta fibers by intra-epidermal needle electrode in humans. Pain. 2002, 96: 247-52. 10.1016/S0304-3959(01)00453-5.CrossRefPubMed
8.
go back to reference Koppert W, Dern SK, Sittl R, Albrecht S, Schüttler J, Schmelz M: A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology. 2001, 95 (2): 395-402. 10.1097/00000542-200108000-00022.CrossRefPubMed Koppert W, Dern SK, Sittl R, Albrecht S, Schüttler J, Schmelz M: A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology. 2001, 95 (2): 395-402. 10.1097/00000542-200108000-00022.CrossRefPubMed
9.
go back to reference Lewis T: Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin Sci. 1936, 2: 373-421. Lewis T: Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin Sci. 1936, 2: 373-421.
10.
go back to reference Filitz J, Ihmsen H, Günther W, Tröster A, Schwilden H, Schüttler J, Koppert W: Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain. 2008, 136 (3): 262-70. 10.1016/j.pain.2007.06.036.CrossRefPubMed Filitz J, Ihmsen H, Günther W, Tröster A, Schwilden H, Schüttler J, Koppert W: Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain. 2008, 136 (3): 262-70. 10.1016/j.pain.2007.06.036.CrossRefPubMed
11.
go back to reference Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W: Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth. 2007, 98 (2): 246-54. 10.1093/bja/ael344.CrossRefPubMed Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W: Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth. 2007, 98 (2): 246-54. 10.1093/bja/ael344.CrossRefPubMed
12.
go back to reference Chizh BA, Dusch M, Puthawala M, Schmelz M, Cookson LM, Martina R, Brown J, Koppert W: The effect of intravenous infusion of adenosine on electrically evoked hyperalgesia in a healthy volunteer model of central sensitization. Anesth Analg. 2004, 99 (3): 816-22. 10.1213/01.ANE.0000132995.35119.99.CrossRefPubMed Chizh BA, Dusch M, Puthawala M, Schmelz M, Cookson LM, Martina R, Brown J, Koppert W: The effect of intravenous infusion of adenosine on electrically evoked hyperalgesia in a healthy volunteer model of central sensitization. Anesth Analg. 2004, 99 (3): 816-22. 10.1213/01.ANE.0000132995.35119.99.CrossRefPubMed
13.
go back to reference Koppert W, Filitz J, Troster A, Ihmsen H, Angst M, Flor H, Schuttler J, Schmelz M: Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. J Pain. 2005, 6 (11): 757-764. 10.1016/j.jpain.2005.07.002.CrossRefPubMed Koppert W, Filitz J, Troster A, Ihmsen H, Angst M, Flor H, Schuttler J, Schmelz M: Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. J Pain. 2005, 6 (11): 757-764. 10.1016/j.jpain.2005.07.002.CrossRefPubMed
14.
go back to reference Koppert W, Angst M, Alsheimer M, Sittl R, Albrecht S, Schüttler J, Schmelz M: Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain. 2003, 106 (1-2): 91-9. 10.1016/S0304-3959(03)00294-X.CrossRefPubMed Koppert W, Angst M, Alsheimer M, Sittl R, Albrecht S, Schüttler J, Schmelz M: Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain. 2003, 106 (1-2): 91-9. 10.1016/S0304-3959(03)00294-X.CrossRefPubMed
15.
go back to reference Koppert W, Ihmsen H, Körber N, Wehrfritz A, Sittl R, Schmelz M, Schüttler J: Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005, 118 (1-2): 15-22. 10.1016/j.pain.2005.06.030.CrossRefPubMed Koppert W, Ihmsen H, Körber N, Wehrfritz A, Sittl R, Schmelz M, Schüttler J: Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005, 118 (1-2): 15-22. 10.1016/j.pain.2005.06.030.CrossRefPubMed
16.
go back to reference Singler B, Tröster A, Manering N, Schüttler J, Koppert W: Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg. 2007, 104 (6): 1397-403. 10.1213/01.ane.0000261305.22324.f3.CrossRefPubMed Singler B, Tröster A, Manering N, Schüttler J, Koppert W: Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg. 2007, 104 (6): 1397-403. 10.1213/01.ane.0000261305.22324.f3.CrossRefPubMed
17.
go back to reference Tröster A, Sittl R, Singler B, Schmelz M, Schüttler J, Koppert W: Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 2006, 105 (5): 1016-23. 10.1097/00000542-200611000-00024.CrossRefPubMed Tröster A, Sittl R, Singler B, Schmelz M, Schüttler J, Koppert W: Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 2006, 105 (5): 1016-23. 10.1097/00000542-200611000-00024.CrossRefPubMed
18.
go back to reference Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114 (1-2): 29-36. 10.1016/j.pain.2004.12.010.CrossRefPubMed Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114 (1-2): 29-36. 10.1016/j.pain.2004.12.010.CrossRefPubMed
19.
go back to reference Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C: Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008, 136 (3): 380-7. 10.1016/j.pain.2007.08.013.CrossRefPubMed Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C: Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008, 136 (3): 380-7. 10.1016/j.pain.2007.08.013.CrossRefPubMed
20.
go back to reference Lecybyl R, Acosta-Guillen J, Hanna M: Development of a new electrical model of neuropathic pain which mimics electrical discharge. J Pain. 2006, 7 (2 s2): Lecybyl R, Acosta-Guillen J, Hanna M: Development of a new electrical model of neuropathic pain which mimics electrical discharge. J Pain. 2006, 7 (2 s2):
21.
go back to reference Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD: Quantitative sensory testing: a comprehensive protocol for clinical trials. European journal of pain (London, England). 2006, 10 (1): 77-88. 10.1016/j.ejpain.2005.02.003.CrossRef Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD: Quantitative sensory testing: a comprehensive protocol for clinical trials. European journal of pain (London, England). 2006, 10 (1): 77-88. 10.1016/j.ejpain.2005.02.003.CrossRef
22.
go back to reference Rolan P: The contribution of clinical pharmacology surrogates and models to drug development- a critical appraisal. Br J Clin Pharmacol. 1997, 44: 219-225. 10.1046/j.1365-2125.1997.t01-1-00583.x.CrossRefPubMedPubMedCentral Rolan P: The contribution of clinical pharmacology surrogates and models to drug development- a critical appraisal. Br J Clin Pharmacol. 1997, 44: 219-225. 10.1046/j.1365-2125.1997.t01-1-00583.x.CrossRefPubMedPubMedCentral
23.
go back to reference Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptom, mechanism and management. The lancet. 1999, 1995-64. 353 Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptom, mechanism and management. The lancet. 1999, 1995-64. 353
24.
go back to reference Treede RD, Handwerker HO, Baumgartner U, Meyer RA, Magerl W: Hyperalgesia and Allodynia: Taxonomy, assessment and mechanisms; Hyperalgesia and Allodynia: molecular mechanisms and clinical implications. Prog Pain Res Menage. 2004, 30: 3-15. Treede RD, Handwerker HO, Baumgartner U, Meyer RA, Magerl W: Hyperalgesia and Allodynia: Taxonomy, assessment and mechanisms; Hyperalgesia and Allodynia: molecular mechanisms and clinical implications. Prog Pain Res Menage. 2004, 30: 3-15.
25.
go back to reference Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD: Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci. 2004, 24 (4): 964-971. 10.1523/JNEUROSCI.1222-03.2004.CrossRefPubMed Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD: Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci. 2004, 24 (4): 964-971. 10.1523/JNEUROSCI.1222-03.2004.CrossRefPubMed
Metadata
Title
Validation, reproducibility and safety of trans dermal electrical stimulation in chronic pain patients and healthy volunteers
Authors
Remigiusz Lecybyl
Juan Acosta
Joydeep Ghoshdastidar
Kinga Stringfellow
Magdi Hanna
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2010
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-10-5

Other articles of this Issue 1/2010

BMC Neurology 1/2010 Go to the issue